Incannex healthcare inc. announces pricing of $12.5 million private placement priced at the market under nasdaq rules

Funds to support the advancement of incannex's ihl-42x phase 2/3 obstructive sleep apnea (osa) clinical program through u.s. phase 2 completion, topline readout, and its expansion into a global phase 3 study. funds to support the advancement of incannex's ihl-42x phase 2/3 obstructive sleep apnea (osa) clinical program through u.s. phase 2 completion, topline readout, and its expansion into a global phase 3 study.
IXHL Ratings Summary
IXHL Quant Ranking